ReviewFrontiers in cell and developmental biology2026
Artificial intelligence in orthopedic regenerative medicine: from design to clinical translational pathways.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Orthopedic regenerative medicine (ORM) addresses musculoskeletal disorders in which effective repair requires coordinated structural reconstruction, biological repair, mechanical adaptation, and functional recovery. These processes generate heterogeneous information across biomaterials, construct design, imaging, intraoperative execution, rehabilitation monitoring, and clinical follow-up. Artificial intelligence (AI) is increasingly relevant for organizing multimodal data and supporting decision-making across regenerative care. This review summarizes current applications of AI in ORM, focusing on regenerative design and fabrication, intraoperative guidance, postoperative monitoring, repair evaluation, and clinical translational pathways. In regenerative design, AI can assist the optimization of material composition, scaffold architecture, biofabrication parameters, and construct performance by linking design variables with biological and biomechanical outcomes. During intervention and recovery, AI-supported systems may improve defect-specific spatial matching, support longitudinal functional assessment, and help identify delayed or unfavorable repair trajectories through integrated analysis of imaging, wearable, and clinical data. The review also discusses translational challenges, including data heterogeneity, limited external validation, algorithmic bias, interpretability, regulatory requirements, and governance constraints. AI may help connect design, intervention, monitoring, and feedback within a continuous analytical workflow, but future progress will require robust datasets, prospective validation, clinically interpretable models, and implementation strategies aligned with regenerative practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.